• 1
    Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003;16:165170.
  • 2
    Jacobs MP, Fischbach GD, Davis MR, et al. Future directions for epilepsy research. Neurology 2001;57:15361542.
  • 3
    Carlen PL, Skinner F, Zhang L, et al. The role of gap junctions in seizures [Review]. Brain Res Brain Res Rev 2000;32:235241.
  • 4
    Bragin A, Wilson CL, Almajano J, et al. High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 2004;45:10171023.
  • 5
    Hosseinzadeh H, Nassiri AM. Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol 2003;3:3.
  • 6
    Gajda Z, Szupera Z, Blazso G, et al. Quinine, a blocker of neuronal Cx36 channels, suppresses seizure activity in rat neocortex in vivo. Epilepsia 2005;46:15811591.
  • 7
    Gajda Z, Gyengesi E, Hermesz E, et al. Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo. Epilepsia 2003;44:15961600.
  • 8
    Nilsen KE, Walker MC, Cock HR. Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat. Epilepsia 2005;46:179188.
  • 9
    Kelso ARC, Nilsen KE, Cock HR. Focal delivery of standard antiepileptic drugs in the tetanus toxin model of epilepsy in rats. J Neurol 2005;252(suppl 2):II/17. Ref Type: Abstract
  • 10
    Draguhn A, Traub RD, Schmitz D, et al. Electrical coupling underlies high-frequency oscillations in the hippocampus in vitro. Nature 1998;394:189192.
  • 11
    Sohl G, Maxeiner S, Willecke K. Expression and functions of neuronal gap junctions. Nat Rev Neurosci 2005;6:191200.
  • 12
    Khosravani H, Pinnegar CR, Mitchell JR, et al. Increased high-frequency oscillations precede in vitro Low-Mg2+ seizures. Epilepsia 2005;46:11881197.
  • 13
    Perez Velazquez JL, Carlen PL. Gap junctions, synchrony and seizures. Trends Neurosci 2000;23:6874.
  • 14
    Traub RD, Whittington MA, Buhl EH, et al. A possible role for gap junctions in generation of very fast EEG oscillations preceding the onset of, and perhaps initiating, seizures. Epilepsia 2001;42:153170.
  • 15
    Samoilova M, Li J, Pelletier MR, et al. Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: increased gap junctional function and expression. J Neurochem 2003;86:687699.
  • 16
    Sohl G, Guldenagel M, Beck H, et al. Expression of connexin genes in hippocampus of kainate-treated and kindled rats under conditions of experimental epilepsy. Brain Res Mol Brain Res 2000;83:4451.
  • 17
    Rouach N, Avignone E, Meme W, et al. Gap junctions and connexin expression in the normal and pathological central nervous system [Review]. Biol Cell 2002;94:457475.
  • 18
    Mas C, Taske N, Deutsch S, et al. Association of the connexin 36 gene with juvenile myoclonic epilepsy. J Med Genet 2004;41:e93.
  • 19
    Benarroch EE. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clinic Proc 2005;80:1326.
  • 20
    Stout CE, Costantin JL, Naus CCG, et al. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 2002;277:1048210488.
  • 21
    Harks EGA, De Roos ADG, Peters PHJ, et al. Fenamates: a novel class of reversible gap junction blockers. J Pharmacol Exp Ther 2001;298:10331041.
  • 22
    Peretz A, Degani N, Nachman R, et al. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol 2005;67:10531066.
  • 23
    Smith AJ, Oxley B, Malpas S, et al. Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid(A) receptors. J Pharmacol Exp Ther 2004;311:601609.
  • 24
    Davidson JS, Baumgarten IM. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication: structure-activity relationships. J Pharmacol Exp Ther 1988;246:11041107.
  • 25
    Jahromi SS, Wentlandt K, Piran S, et al. Anticonvulsant actions of gap junctional blockers in an in vitro seizure model. J Neurophysiol 2002;88:18931902.
  • 26
    Ross FM, Gwyn P, Spanswick D, et al. Carbenoxolone depresses spontaneous epileptiform activity in the CA1 region of rat hippocampal slices. Neuroscience 2000;100:789796.
  • 27
    Kohling R, Gladwell SJ, Bracci E, et al. Prolonged epileptiform bursting induced by 0-Mg(2+) in rat hippocampal slices depends on gap junctional coupling. Neuroscience 2001;105:579587.
  • 28
    Nyikos L, Lasztozi B, Antal K, et al. Desynchronisation of spontaneously recurrent experimental seizures proceeds with a single rhythm. Neuroscience 2003;121:705717.
  • 29
    Gigout S, Louvel J, Pumain R. Antiepileptic effect of a gap junction blocker in a model of absence epilepsy. Epilepsia 2005;46(suppl 6):361.
  • 30
    Edwards HE, Vimal S, Burnham WM. The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses. Epilepsia 2005;46:18881897.
  • 31
    Tian GF, Azmi H, Takano T, et al. An astrocytic basis of epilepsy. Nat Med 2005;11:973981.
  • 32
    Nilsen KE, Cock HR. Focal treatment for refractory epilepsy: hope for the future? Brain Res Rev 2004;44:141153.
  • 33
    Wang PP, Frazier J, Brem H. Local drug delivery to the brain. Adv Drug Deliv Rev 2002;54:9871013.
  • 34
    Carson BS, Wu QZ, Tyler B, et al. New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. J Neuro-Oncol 2002;60:151158.
  • 35
    Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003;9:589595.